Compounds > 1-naphthylamine
Page last updated: 2024-08-18

1-naphthylamine and Carcinoma, Hepatocellular

1-naphthylamine has been researched along with Carcinoma, Hepatocellular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ichimura, Y; Imamura, R; Kojima, H; Komatsu, M; Mashino, T; Nagano, T; Ohe, T; Okabe, T; Takahashi, K; Yamamoto, M; Yasuda, D1
Deng, J; Li, Y; Luo, Q; Zhang, Z1
Deng, JJ; Li, Y; Luo, QY; Zhang, ZZ1
Lai, Y; Li, Y; Luo, Q; Zhang, Z1
ASHTON, MJ; CLAYSON, DB1

Other Studies

5 other study(ies) available for 1-naphthylamine and Carcinoma, Hepatocellular

ArticleYear
Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line.
    Free radical research, 2020, Volume: 54, Issue:11-12

    Topics: 1-Naphthylamine; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Naphthalenes; NF-E2-Related Factor 2; Phosphorylation; Protein Interaction Domains and Motifs; RNA-Binding Proteins; Sorafenib; Sulfonamides

2020
PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Chemico-biological interactions, 2015, Jan-25, Volume: 226

    Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cyclin B1; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Naphthalimides; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Up-Regulation

2015
[4-amino-1,8-naphthalimide on the Sensitive effect of arsenic trioxide in hepatocellular carcinoma cells].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2015, Volume: 46, Issue:2

    Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Survival; DNA Damage; DNA Repair; Hep G2 Cells; Humans; Liver Neoplasms; Naphthalimides; Oxides; Quinolones

2015
The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    The Journal of toxicological sciences, 2015, Volume: 40, Issue:3

    Topics: 1-Naphthylamine; Acetylcysteine; Antineoplastic Agents; Antioxidants; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Damage; Hep G2 Cells; Humans; Inactivation, Metabolic; Liver Neoplasms; Naphthalimides; NF-kappa B; Oxidative Stress; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Reactive Oxygen Species

2015
THE METABOLISM OF 1-NAPHTHYLAMINE AND ITS BEARING ON THE MODE OF CARCINOGENESIS OF THE AROMATIC AMINES.
    Acta - Unio Internationalis Contra Cancrum, 1963, Volume: 19

    Topics: 1-Naphthylamine; Amines; Aniline Compounds; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Carnivora; Cricetinae; Guinea Pigs; Hydroxylamines; Liver Neoplasms; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Rabbits; Rats; Research; Urinary Bladder Neoplasms

1963